Navigation Links
Cardica Announces Fiscal 2013 Second Quarter Financial Results
Date:1/31/2013

s can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.

About Cardica Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 44,100 units throughout the world. In addition, Cardica is developing the Cardica® MicroCutter XCHANGE™ 30, a cartridge-based microcutter device with a five-millimeter shaft diameter, and the Cardica® MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling device. Both MicroCutter devices are designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 30 and XPRESS 30 products require 510(k) review and are not yet commercially available in the U.S. 

Forward-Looking StatementsThe statements in this press release regarding Cardica's plans to extend its commercial launch of the MicroCutter XCHANGE™ 30 gradually, and its intention to enroll additional patients in its European clinical trial using the commercial version of the XCHANGE 30 in the weeks ahead, with a planned enrollment completion in the second quarter of calendar year 2013,  are "forward-looking statements." The words "intend" and "plan" are intended to identify these forward-lookin
'/>"/>

SOURCE Cardica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardica To Announce Fiscal 2013 Second Quarter Financial Results On Thursday, January 31, 2013
2. Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference
3. Cardica Announces Fiscal 2013 First Quarter Financial Results
4. Cardica To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference
5. Cardica Announces Fiscal 2012 Fourth Quarter And Year End Financial Results
6. Cardica To Announce Fiscal 2012 Fourth Quarter And Full Year Financial Results On Thursday, August 2, 2012
7. Cardica Announces Fiscal 2012 Third Quarter Financial Results
8. Oclaro Announces Second Quarter Fiscal Year 2013 Financial Results
9. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
10. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
11. Blue Belt Technologies Announces First U.S. Sale of NavioPFS Surgical System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
(Date:7/28/2015)... Ala. , July 28, 2015   Vincari ... for surgeons , has just hired John O,Neil ... Business Development. John has over 30 years of diverse ... roles. Mr. O,Neil,s executive healthcare experience coupled with Vincari,s ... active surgeon allows Vincari to address the challenges both ...
(Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3
... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
(Date:7/29/2015)... ... 29, 2015 , ... One may not expect to encounter a kickball game ... exactly what was happening on the campus of Piedmont Crossing , a local ... Kids Only , a five-star childcare center which operates on the same campus. ...
(Date:7/29/2015)... Orange County, CA (PRWEB) , ... July 29, 2015 , ... ... xylitol-based mouthwashes in a variety of gourmet flavors. , Nature’s Artisan was founded by ... in the Post-Baccalaureate program at the UCLA School of Dentistry. Tina was amazed when ...
(Date:7/28/2015)... ... ... Talking About Your Product Pipeline:, How FDA and SEC Regulate Life Sciences ... http://www.fdanews.com/productpipeline , When a company has a product in development, whether drug, device ... regulated by the FDA. , At the same time, the SEC requires that information ...
(Date:7/28/2015)... ... ... City Sports, a specialty sports retailer and a premiere destination for dedicated athletes ... Hanaka, who has served on the Board of Directors for City Sports since 2008 ... has had previous tenures as Chairman and CEO of Golfsmith International Holdings, Inc., Chairman ...
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or ... This would allow insurers to access the on-board vehicle data and better understand customer ... it comes to sharing vehicle data. However times are changing and automakers realize that ...
Breaking Medicine News(10 mins):Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:City Sports Names Marty Hanaka CEO 2Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3
... , THURSDAY, Aug. 4 (HealthDay News) -- A growing number ... the clot-busting drug tissue plasminogen activator (tPA) to treat stroke ... An ischemic stroke is caused by blocked blood flow to ... residents who say they,re comfortable using tPA rose from 73 ...
... for most people means time spent outdoors, which could ... diseases, such as "rickettsial diseases" infectious diseases spread ... ticks and mites. Now a $1.6 million grant ... an entomologist at the University of California, Riverside to ...
... of Cardiology has issued the following statement today: ... the early termination of the PALLAS trial (a randomised ... atrial fibrillation and cardiovascular risk) because of adverse outcomes ... the Management of Atrial Fibrillation (AF) recommend the use ...
... doubles healthcare costs associated with the disease and threatens ... according to researchers at National Jewish Health. The research ... Archives of Allergy, Asthma & Immunology that children with ... days of school each year, compared to 2 or ...
... -- Women with the eating disorders anorexia and bulimia may ... a new study has found. U.K. researchers asked 11,088 ... of gestation. Of those women, 171 (1.5 percent) had anorexia ... bulimia, and another 82 (0.7 percent) had experienced both conditions. ...
... Warburton and Dr Gareth Barker in the University,s School of Physiology ... has investigated why we can recognise faces much better if we ... them in the first place. The study found that when ... face, occurred in a particular place, or at a particular time, ...
Cached Medicine News:Health News:More Neurology Residents Using Clot-Busting Drug for Stroke 2Health News:UC Riverside entomologist to study diseases transmitted by ticks 2Health News:UC Riverside entomologist to study diseases transmitted by ticks 3Health News:ESC announces review of Atrial Fibrillation Guidelines 2Health News:Poorly controlled asthma costly 2Health News:Eating Disorders Can Harm Women's Fertility 2Health News:Have we met before? Scientists show why the brain has the answer 2
Ideal for abdominal, hip, thigh and knee procedures....
Body Suit w/Bra above knee...
Gynecomastia Vest...
Male Compression Vest, Front Closure...
Medicine Products: